NEWS

Crunchtime for Mesoblast as legal threats loom

MELBOURNE: In an early morning investor call two weeks ago, stem cell treatments ... read more

Mesoblast faces prospect of legal threats and class actions

MELBOURNE: In an early morning investor call two weeks ago, stem cell treatments ... read more

Soft first half sees Altium revise previous guidance

MELBOURNE: ASX tech firm Altium says a slow first half of the year ... read more

Mayne Pharma contraceptive product set to hit the US

MELBOURNE: ASX- listed pharmaceuticals maker Mayne is kicking off the week with new ... read more